Washington State Life Science Investment Report – October 2023

• Policy Blog
• 2026

Policy Blog – January 16, 2026 – Contract Pharmacy Manufacturer Mandate Bill Receives First Legislative Hearing in Olympia

On Friday morning, the Senate Health and Long-Term Care Committee heard testimony on SB 5981, legislation that would allow unchecked expansion of hospital contract pharmacy arrangements in the 340B Drug Pricing Program. As we noted last week, SB 5981 is not a narrow technical fix. It would codify practices that allow hospital systems to use […]

• Industry Reports
• 2025

Washington State Life Science Investment Report – November 2025

• Policy Blog
• 2026

Policy Blog – January 12, 2026 – 2026 State Legislative Session Kicks Off With Budget and Health Care Debates Ahead

The 2026 legislative session of the Washington State Legislature began Monday, kicking off the 60-day short session that will run through mid-March. Lawmakers from both chambers return to Olympia following an active pre session period, with dozens of bills already pre filed on issues ranging from health care and education to housing and affordability. The […]

• Policy Agenda
• 2026

2026 LSW Legislative Agenda

The 2026 Washington State legislative session begins with lawmakers returning to Olympia for a short, 60-day session that will shape state policy through mid-March. Life Science Washington anticipates significant debates around health care policy and proposals to raise new taxes and will be actively engaged throughout the session to protect a strong, competitive business environment […]